ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126

  • Authors:
    • Junqing Wang
    • Yunyun Zhou
    • Xiaochun Fei
    • Xuehua Chen
    • Jiqi Yan
    • Bingya Liu
    • Zhenggang Zhu
  • View Affiliations

  • Published online on: February 16, 2017     https://doi.org/10.3892/or.2017.5460
  • Pages: 2033-2040
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A disintegrin and metalloproteinase domain 9 (ADAM9) is a membrane-anchored protein implicated in cell-cell and cell-matrix interactions, including the process of tumorigenesis. However, the role of ADAM9 in gastric cancer (GC) has not been clearly illustrated. In the present study, we found aberrant overexpression of ADAM9 in both GC tissues and cell lines. The expression of ADAM9 was significantly correlated with patient clinicopathological features including tumor size, local invasion, lymph node metastasis and tumor‑node‑metastasis (TNM) stage. Knockdown of ADAM9 in GC SGC-7901 cells, which presented the highest ADAM9 expression among the cell lines, induced a dramatic suppression of cell proliferation along with the arrest of the cell cycle in the G0/G1 phase. Furthermore, we validated that the 3' untranslated region of ADAM9 mRNA could be bound by miR-126, a suppressor in GC, and overexpression of miR-126 significantly downregulated ADAM9 in the GC cells. In conclusion, ADAM9 functions as a tumor promoter in GC by modulating GC cell proliferation. ADAM9 could possibly be regarded as a biomarker for GC diagnosis and prevention. Moreover, as directly targeted by miR-126 in GC, ADAM9 may be a potential target for GC therapeutic treatment which warrants intensive study.
View Figures
View References

Related Articles

Journal Cover

April-2017
Volume 37 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang J, Zhou Y, Fei X, Chen X, Yan J, Liu B and Zhu Z: ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126. Oncol Rep 37: 2033-2040, 2017
APA
Wang, J., Zhou, Y., Fei, X., Chen, X., Yan, J., Liu, B., & Zhu, Z. (2017). ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126. Oncology Reports, 37, 2033-2040. https://doi.org/10.3892/or.2017.5460
MLA
Wang, J., Zhou, Y., Fei, X., Chen, X., Yan, J., Liu, B., Zhu, Z."ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126". Oncology Reports 37.4 (2017): 2033-2040.
Chicago
Wang, J., Zhou, Y., Fei, X., Chen, X., Yan, J., Liu, B., Zhu, Z."ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126". Oncology Reports 37, no. 4 (2017): 2033-2040. https://doi.org/10.3892/or.2017.5460